TOP1 as a molecular signature in melanoma progression and resistance to BRAF and MEK inhibitors (2018)
- Autores:
- Autor USP: ENGLER, SILVYA STUCHI MARIA - FCF
- Unidade: FCF
- Assuntos: MELANOMA; IMUNOTERAPIA
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Resumos
- Nome do evento: International Symposium on Pathophysiology and Toxicology/ISPAT
-
ABNT
OLIVEIRA, Erica Aparecida de et al. TOP1 as a molecular signature in melanoma progression and resistance to BRAF and MEK inhibitors. 2018, Anais.. São Paulo: FCF/USP, 2018. Disponível em: http://simpac.wixsite.com/simpac/symposium-publications. Acesso em: 28 mar. 2024. -
APA
Oliveira, E. A. de, Fernandes, D. K. A., Watanabe, L. R. M., Consolaro, M. E. L., & Maria-Engler, S. S. (2018). TOP1 as a molecular signature in melanoma progression and resistance to BRAF and MEK inhibitors. In Resumos. São Paulo: FCF/USP. Recuperado de http://simpac.wixsite.com/simpac/symposium-publications -
NLM
Oliveira EA de, Fernandes DKA, Watanabe LRM, Consolaro MEL, Maria-Engler SS. TOP1 as a molecular signature in melanoma progression and resistance to BRAF and MEK inhibitors [Internet]. Resumos. 2018 ;[citado 2024 mar. 28 ] Available from: http://simpac.wixsite.com/simpac/symposium-publications -
Vancouver
Oliveira EA de, Fernandes DKA, Watanabe LRM, Consolaro MEL, Maria-Engler SS. TOP1 as a molecular signature in melanoma progression and resistance to BRAF and MEK inhibitors [Internet]. Resumos. 2018 ;[citado 2024 mar. 28 ] Available from: http://simpac.wixsite.com/simpac/symposium-publications - Adaptation of uveal melanoma cells to MEK inhibition can be overcome through HDAC inhibition
- Resenha sem título próprio
- Reck-mediated inhibition of glioma migration and invasion
- Resenha sem título próprio
- Imunolocalização de RECK e atividade de MMP-2 e MMP-9 nas linhagens de glioma humano A172 e T98G durante o processo invasivo
- RECK-tumor suppressor gene is overexpressed in vermurafenib-resistant human melanoma cells
- Apoptosis expression in vemurafenib-resistant melanoma cells induced by curcumin analog DM-1
- RECK is required for migration and invasiveness in melanoma after vemurafenib treatment
- Epithelial mesenchymal transition as an alternative pathway in vemurafenib and vemurafenib/trametinib chemoresistant melanoma
- Evaluation of antimetastatic activity in vemurafenib resistant melanoma cell lines after DM-1 treatment
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas